We are dedicated to industry-standard knowledge and quality
Helping You Globalize the Right Way
CSOFT’s experienced and dedicated global regulatory submission specialists help companies comply with these demanding multilingual documentation requirements for submissions while providing the highest linguistic quality
We can help you attain the appropriate, accurate, and sustainable compliance required throughout the entire submission process. We ensure our clients receive the necessary certifications to successfully enter emerging markets.
Medical Translation with a Focus on Precision
Our translation solutions are intended for document types relating to every stage of product development life cycle.
Quality in translation is extremely important, but within the life sciences industry, incorrect translations could literally be life threatening. We use industry-standard processes, however, we also offer flexibility for each customer to allow for their companies’ success, no matter the process.
Industries We Serve
Who We Are
CSOFT Health Sciences provides end-to-end medical translations for all phases of the product lifecycle, from pre-clinical to post-launch. We also specialize in market access consulting, medical writing, and CTD/eCTD submissions with the FDA, EMA, and NMPA.
Our operations are compliant with ISO 17100 and certified in ISO 9001:2015 and ISO 13485:2016, ensuring our customized solutions meet the rigorous regulatory requirements of global submissions.
The Power of Linguistic Expertise
Right Tools. Right Resources
Tools we use
CAT Tools: Trados, MemoQ, Transifex, Smartling, WordServer
We translate all document types (.ai, .doc, .pdf, .ppt, .xlx, .css, .php, .html, .xml, .mml, .txt, .mpg, .mov, .zip, .psd, and more)
Linguists we hire
Our native in-country subject-matter experts with at least 7 years’ experience go through a rigorous certification process and are guided with customer experience surveys
Methodologies we employ
Customized solutions
Translation Memory
Style Guides & Glossary
PLLP
CSOFT works extensively with medical professionals who are dedicated to prevalent therapeutic areas
- Cardiology
- Dental
- Dermatology
- Gastroenterology
- Genetic Disease
- Hematology
- Hepatology
- Immunology
- Infections
- Neurology
- Oncology
- Orthopedics
- Pediatrics
- Psychology
- Rare Diseases
- Women’s Health
Start Your Global Journey
Headquarters
501 Boylston Street, 10th Floor
Boston, MA 02116
Phone
+1-617-263-8950 (US/Europe)
+86-10-5736-6000 (Asia)
The Knowledge Vault
Stay in the know
CSOFT life science blog aims to provide a better understanding of complex diseases, and regulatory policies from conducting experiments to introducing new type of drugs into the market.
Interviewing CSOFT Health Sciences Strategy Advisor, VP Region Head Medical Amgen, Professor Victoria Elegant
CSOFT Health Sciences and Professor Victoria Elegant convened for another conversation after her previous Women’s day interview (here). She has been actively involved in managing the COVID-19 pandemic situation with her staff. She recently was a panelist on a MAPS...
Remote Devices: A New Age of Patient Centricity
A new age of patient centricity has dawned, and the need for remote patient engagement has become more crucial than ever. From being able to remotely visit COVID-19 patients, to continuously tracking patients participating in clinical trials, remote technology helps...
How Real-World Data and Real-World Evidence Are Revealing the Patient’s Untold Story
As our world is constantly changing, the healthcare industry is adapting to better serve patients and improve lives around the world. While healthcare is shifting to become more patient-centric, additional data from the patient’s day-to-day life is needed to enhance...
Exploring the World of Vaccinations
Explore the world of vaccinations with Professor K in understanding what they are, how they work, and the challenges they face in development and implementation, especially for COVID-19.
FDA Announces Exemptions and Exclusions from Certain Requirements in the Drug Supply Chain Security Act
Yesterday (4/30) the FDA lifted some of the security requirements in the Drug Supply Chain Security Act to help expedite adequate distribution of prescription drugs due to COVID-19. These exemptions and exclusions apply to...
Amazing Cooperation Between Companies to Meet Global Demands for Pandemic-Response Equipment
There has been amazing cooperation by companies with global supply chains to come together and produce surplus PPE and ventilators for domestic and international markets. Communicating effectively across multi-lingual global supply chains is more important than ever...
